Characterization of the stable L-arginine-derived relaxing factor released from cytokine-stimulated vascular smooth muscle cells as an NG-hydroxyl-L-arginine-nitric oxide adduct.

Documenti analoghi

• Effect of cyclic GMP-dependent vasodilators on the expression of inducible nitric oxide synthase in vascular smooth muscle cells: role of cyclic AMP.
  di: Boese, M., et al.
  Pubblicazione: (1996)
• Increased serum NG-hydroxy-L-arginine in patients with rheumatoid arthritis and systemic lupus erythematosus as an index of an increased nitric oxide synthase activity
  di: Wigand, R., et al.
  Pubblicazione: (1997)
• L-NG-monomethyl arginine and L-NG-nitro arginine inhibit non-adrenergic, non-cholinergic relaxation of the mouse anococcygeus muscle.
  di: Gibson, A., et al.
  Pubblicazione: (1990)
• Inhibition of the release of endothelium-derived relaxing factor in vitro and in vivo by dipeptides containing NG-nitro-L-arginine.
  di: Thiemermann, C., et al.
  Pubblicazione: (1991)
• Nitric oxide and another potent vasodilator are formed from NG-hydroxy-L-arginine by cultured endothelial cells.
  di: Zembowicz, A, et al.
  Pubblicazione: (1991)